188 GENES FOUND
Show / hide columns
XML |
RDF |
TSV |
« prev | Page
of 4 | next »
NPAS2 Neuronal PAS domain protein 2 Predicted intracellular proteins Transcription factors Nucleoplasm Mixed
NPB Neuropeptide B Predicted secreted proteins Tissue enhanced
NPW Neuropeptide W Predicted intracellular proteins Predicted secreted proteins Tissue enhanced
NR2F1 Nuclear receptor subfamily 2, group F, member 1 Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors Nucleoplasm Cytosol Mixed
NR3C2 Nuclear receptor subfamily 3, group C, member 2 Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors Nucleoplasm Mixed
NRG2 Neuregulin 2 Cancer-related genes Predicted membrane proteins Nucleus Nucleoli Tissue enhanced
NRGN Neurogranin (protein kinase C substrate, RC3) Predicted intracellular proteins Tissue enriched
NTN4 Netrin 4 Cancer-related genes Predicted intracellular proteins Predicted secreted proteins Tissue enhanced
OPLAH 5-oxoprolinase (ATP-hydrolysing) Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Nucleoli fibrillar center Tissue enhanced
OR2W3 Olfactory receptor, family 2, subfamily W, member 3 G-protein coupled receptors Predicted membrane proteins Tissue enhanced
OR8G5 Olfactory receptor, family 8, subfamily G, member 5 G-protein coupled receptors Predicted membrane proteins Tissue enriched
PAX9 Paired box 9 Disease related genes Predicted intracellular proteins Transcription factors Nucleoplasm Mitochondria Group enriched
PCDHA12 Protocadherin alpha 12 Predicted membrane proteins Cytosol Tissue enhanced
PCDHA13 Protocadherin alpha 13 Predicted membrane proteins Tissue enriched
PCDHAC1 Protocadherin alpha subfamily C, 1 Predicted membrane proteins Nucleus Nucleoli Vesicles Tissue enriched
PCSK1N Proprotein convertase subtilisin/kexin type 1 inhibitor Predicted secreted proteins Vesicles Tissue enhanced
PGM5 Phosphoglucomutase 5 Predicted intracellular proteins Tissue enhanced
PHEX Phosphate regulating endopeptidase homolog, X-linked Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Mixed
PHLDA2 Pleckstrin homology-like domain, family A, member 2 Predicted intracellular proteins Nucleoli Tissue enriched
PKIB Protein kinase (cAMP-dependent, catalytic) inhibitor beta Predicted intracellular proteins Tissue enhanced
PLA2G7 Phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins Vesicles Mixed
PLCXD3 Phosphatidylinositol-specific phospholipase C, X domain containing 3 Predicted intracellular proteins Golgi apparatus Tissue enhanced
PLEK2 Pleckstrin 2 Predicted intracellular proteins Vesicles Cytosol Mixed
PLIN4 Perilipin 4 Plasma proteins Predicted intracellular proteins Vesicles Lipid droplets Plasma membrane Cytosol Tissue enriched
PPARG Peroxisome proliferator-activated receptor gamma Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors Nucleus Vesicles Tissue enhanced
PPFIA3 Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 Predicted intracellular proteins Nucleoli fibrillar center Vesicles Group enriched
PPP1R3G Protein phosphatase 1, regulatory subunit 3G Predicted intracellular proteins Mixed
PPP2R2C Protein phosphatase 2, regulatory subunit B, gamma Predicted intracellular proteins Cytosol Tissue enhanced
PPP2R3B Protein phosphatase 2, regulatory subunit B'', beta Predicted intracellular proteins Endoplasmic reticulum Tissue enhanced
PTGER1 Prostaglandin E receptor 1 (subtype EP1), 42kDa FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters Tissue enhanced
PTPRH Protein tyrosine phosphatase, receptor type, H Enzymes Predicted membrane proteins Mitochondria Tissue enhanced
RAMP1 Receptor (G protein-coupled) activity modifying protein 1 FDA approved drug targets Predicted membrane proteins Nucleoplasm Nuclear membrane Tissue enhanced
RASL11A RAS-like, family 11, member A Predicted intracellular proteins Nuclear bodies Mixed
RBP4 Retinol binding protein 4, plasma Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins Tissue enriched
RGS2 Regulator of G-protein signaling 2 Plasma proteins Predicted intracellular proteins Cytosol Expressed in all
RHOF Ras homolog family member F (in filopodia) Plasma proteins Predicted intracellular proteins Nucleus Golgi apparatus Expressed in all
RIN2 Ras and Rab interactor 2 Disease related genes Predicted intracellular proteins Nucleoli Golgi apparatus Cytosol Expressed in all
RP11-192H23.4 Predicted intracellular proteins Nucleoplasm Vesicles Plasma membrane Tissue enhanced
RPS6KA6 Ribosomal protein S6 kinase, 90kDa, polypeptide 6 Enzymes Predicted intracellular proteins Nucleus Nucleoli Mitochondria Tissue enhanced
SAMD3 Sterile alpha motif domain containing 3 Predicted intracellular proteins Tissue enhanced
SCARA5 Scavenger receptor class A, member 5 Predicted intracellular proteins Predicted membrane proteins Mixed
SCGB3A2 Secretoglobin, family 3A, member 2 Predicted intracellular proteins Predicted secreted proteins Tissue enriched
SIDT1 SID1 transmembrane family, member 1 Predicted membrane proteins Transporters Mixed
SIM2 Single-minded family bHLH transcription factor 2 Predicted intracellular proteins Transcription factors Nucleoplasm Nuclear bodies Tissue enhanced
SLAMF9 SLAM family member 9 Predicted membrane proteins Tissue enhanced
SLC35F2 Solute carrier family 35, member F2 Predicted membrane proteins Transporters Mitochondria Mixed
SLC9A3R2 Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 Predicted intracellular proteins Transporters Plasma membrane Mixed
SLCO1B3 Solute carrier organic anion transporter family, member 1B3 Disease related genes Potential drug targets Predicted membrane proteins Transporters Plasma membrane Tissue enriched
SLCO4A1 Solute carrier organic anion transporter family, member 4A1 Predicted membrane proteins Transporters Cell Junctions Mixed
SLN Sarcolipin Predicted membrane proteins Transporters Microtubules Tissue enriched
« prev | Page
of 4 | next »